Document Detail


Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages.
MedLine Citation:
PMID:  22134879     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Bacillus anthracis toxins may be attenuated if macrophages could neutralize toxins upon contact or exposure. Glycoconjugate-bearing polymers, which have been shown to bind to Bacillus spores, were tested for recognition and binding of protective antigen (PA), lethal factor (LF), and edema factor (EF) toxins. We have demonstrated modulation of macrophage activity following exposure to these toxins. Without glycoconjugate (GC) activation, murine macrophages were killed by Bacillus toxins. GCs were shown to have a protective influence, sparing macrophages from toxin-induced cell death, as shown by increased macrophage cell viability based on trypan blue assay. Increased levels of inducible nitric oxide (NO) production by macrophages in presence of GCs suggest that GCs provide an activation signal for macrophages and stimulate their function. Results hint to GCs that promote neutralization of Bacillus toxins, block toxin-induced macrophage death, while increasing macrophage activation. Polymeric GCs may suggest novel approaches to improve existing or develop new vaccines as well as immunotherapeutics.
Authors:
Olga Tarasenko; Ashley Scott; Lee Soderberg; Pierre Alusta
Related Documents :
16603079 - Apolipoprotein e-specific innate immune response in astrocytes from targeted replacemen...
19043589 - Modulation of the nf-kappab pathway by bordetella pertussis filamentous hemagglutinin.
11549849 - Methylprednisolone accelerates the resolution of glomerulonephritis by sensitizing mesa...
11717189 - Nf-kappa b activation plays an important role in the il-4-induced protection from apopt...
20600759 - Tlr4-mediated activation of macrophages by the polysaccharide fraction from polyporus u...
14960579 - Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18...
10344219 - Gm-csf as a systemic adjuvant in a phase ii prostate cancer vaccine trial.
12430859 - A novel therapeutic approach for hematological malignancies based on cellular different...
11561209 - Apoptosis: live or die--hard work either way!
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-2
Journal Detail:
Title:  Glycoconjugate journal     Volume:  -     ISSN:  1573-4986     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8603310     Medline TA:  Glycoconj J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Biology, University of Arkansas at Little Rock, 2801 South University Ave., Little Rock, AR, 72204, USA, omtarasenko@ualr.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathophysiology of Microwave Radiation: Effect on Rat Brain.
Next Document:  Validity of the Oxford classification of IgA nephropathy in children.